[ad_1]
Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.
[ad_2]
Source link
Ozempic maker Novo Nordisk boots CEO over stock-price fall